AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9602581 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedation score
Number of subjects: 25
Study 7973964 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanically elicited electromyograms
Number of subjects: 89
Study 7973964 — intervention group
Group type: COMPARATOR
Intervention: Other methods
Number of subjects: 89
Study 2788222 — intervention group
Group type: EXPERIMENTAL
Intervention: Seventh-grade interventions based on the social influences model
Number of subjects: 7124
Study 2788222 — intervention group
Group type: COMPARATOR
Intervention: Other conditions (not specified)
Number of subjects: 7124
Study 29519133 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl-soaked biodegradable synthetic polyurethane foams packing (50 mcg)
Number of subjects: 152
Study 29519133 — intervention group
Group type: COMPARATOR
Intervention: Saline-soaked packing
Number of subjects: 152
Study 29519133 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl-soaked packing
Number of subjects: 152
Study 27814918 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-tiered echocardiographic analysis (FTEA) method
Number of subjects: 436
Study 27814918 — intervention group
Group type: COMPARATOR
Intervention: Conventional diagnostic method
Number of subjects: 436
Study 25759859 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX)
Number of subjects: 30
Study 25759859 — intervention group
Group type: EXPERIMENTAL
Intervention: Persica mouthwash
Number of subjects: 30
Study 23816755 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine combined with irbesartan
Number of subjects: 218
Study 23816755 — intervention group
Group type: COMPARATOR
Intervention: Felodipine combined with metoprolol
Number of subjects: 218
Study 21317777 — intervention group
Group type: EXPERIMENTAL
Intervention: Preincision intravenous normal saline and direct infiltration of dexmedetomidine (1 μg/kg) to the surgical wounds at the end of the surgery (Group P)
Number of subjects: 99
Study 21317777 — intervention group
Group type: EXPERIMENTAL
Intervention: Preincision intravenous dexmedetomidine (1 mcg/kg) and direct infiltration of normal saline to the surgical wounds at the end of the surgery (Group D)
Number of subjects: 99
Study 21317777 — intervention group
Group type: COMPARATOR
Intervention: Normal saline at both time points (Group N)
Number of subjects: 99
Study 19571773 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluid analysis
Number of subjects: 0
Study 16179403 — intervention group
Group type: EXPERIMENTAL
Intervention: Local cooling at -4 degrees C/min with bretylium tosylate (BT)
Number of subjects: 0
Study 16179403 — intervention group
Group type: EXPERIMENTAL
Intervention: Local cooling at -0.33 degrees C/min
Number of subjects: 0
Study 16179403 — intervention group
Group type: EXPERIMENTAL
Intervention: N(G)-nitro-L-arginine methyl ester (L-NAME)
Number of subjects: 0
Study 16179403 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid local cooling (-4 degrees C/min) to 24 degrees C
Number of subjects: 0
Study 16179403 — intervention group
Group type: EXPERIMENTAL
Intervention: After 35-45 min of local cooling at BT + saline sites
Number of subjects: 0
Study 16179403 — intervention group
Group type: EXPERIMENTAL
Intervention: After 35-45 min of local cooling at BT + L-NAME sites
Number of subjects: 0
Study 15750259 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (an angiotensin II receptor blocker)
Number of subjects: 3000
Study 11308252 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate (1.6 g daily orally) for 3 years
Number of subjects: 61
Study 11308252 — intervention group
Group type: COMPARATOR
Intervention: Antioestrogen therapy (tamoxifen 20 mg or toremifene 60 mg daily) for 3 years
Number of subjects: 61
Study 11308252 — intervention group
Group type: COMPARATOR
Intervention: Recent HRT users
Number of subjects: 61
Study 9329386 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg MK-677
Number of subjects: 9
Study 9329386 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg MK-677
Number of subjects: 9
Study 9329386 — intervention group
Group type: COMPARATOR
Intervention: MK-677
Number of subjects: 9
Study 7933710 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenic group with SPEM dysfunction
Number of subjects: 10
Study 7933710 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenic group without SPEM dysfunction
Number of subjects: 10
Study 7933710 — intervention group
Group type: COMPARATOR
Intervention: Normal control group
Number of subjects: 10
Study 3142943 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg rt-PA intravenously over 3 h
Number of subjects: 721
Study 3142943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 721
Study 4177613 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-D immunoglobulin (250 mug)
Number of subjects: 662
Study 4177613 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 662
Study 31651213 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Psychological Therapy (IPT) + Emotional Management Training (EMT)
Number of subjects: 77
Study 31651213 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 77
Study 29417768 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive expandable channel
Number of subjects: 48
Study 29417768 — intervention group
Group type: COMPARATOR
Intervention: Traditional open posterior operation approach
Number of subjects: 48
Study 25497473 — intervention group
Group type: COMPARATOR
Intervention: escitalopram+placebo
Number of subjects: 665
Study 25497473 — intervention group
Group type: EXPERIMENTAL
Intervention: bupropion-sustained-release+escitalopram
Number of subjects: 665
Study 25497473 — intervention group
Group type: EXPERIMENTAL
Intervention: venlafaxine-extended-release+mirtazapine
Number of subjects: 665
Study 23192403 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (nonobese)
Number of subjects: 1190
Study 23192403 — intervention group
Group type: COMPARATOR
Intervention: Operative treatment (obese)
Number of subjects: 1190
Study 23192403 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative treatment (nonobese)
Number of subjects: 1190
Study 23192403 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment (obese)
Number of subjects: 1190
Study 23192403 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (both groups)
Number of subjects: 1190
Study 17144515 — intervention group
Group type: EXPERIMENTAL
Intervention: FDT
Number of subjects: 57
Study 17144515 — intervention group
Group type: COMPARATOR
Intervention: SAP
Number of subjects: 57
Study 12857467 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Arginine (L-Arg) treatment
Number of subjects: 0
Study 12857467 — intervention group
Group type: COMPARATOR
Intervention: Control group (HIRI group)
Number of subjects: 0
Study 10365899 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyloriset EIA‐G New (a quantitative enzyme‐linked immunosorbent assay)
Number of subjects: 115
Study 10365899 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 115
Study 8983917 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (T)
Number of subjects: 24
Study 8983917 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (T) + Selenium supplementation (Sel)
Number of subjects: 24
Study 8983917 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exercise (E)
Number of subjects: 24
Study 8983917 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of acute exercise (E) + endurance training (T)
Number of subjects: 24
Study 8983917 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of acute exercise (E) + endurance training (T) + selenium supplementation (Sel)
Number of subjects: 24
Study 8983917 — intervention group
Group type: COMPARATOR
Intervention: Selenium supplementation (Sel)
Number of subjects: 24
Study 2012724 — intervention group
Group type: EXPERIMENTAL
Intervention: Measures concerning arterial diameter and lumen volume
Number of subjects: 107
Study 2012724 — intervention group
Group type: EXPERIMENTAL
Intervention: Measures concerning edge irregularity and localized stenosis
Number of subjects: 107
Study 2012724 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean diameter and square root of lumen volume
Number of subjects: 107
Study 2012724 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall measures
Number of subjects: 107
Study 6294793 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime (2 g daily for 5-10 days, max 12 g in severe cases)
Number of subjects: 477
Study 6294793 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime (2 g daily for 5-10 days)
Number of subjects: 477
Study 6294793 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin (2 g daily for 5-10 days)
Number of subjects: 477
Study 6294793 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 477
Study 6294793 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 477
Study 29471266 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV-A genotype detection
Number of subjects: 20359
Study 29471266 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV-B genotype detection
Number of subjects: 20359
Study 28283245 — intervention group
Group type: EXPERIMENTAL
Intervention: tranexamic acid
Number of subjects: 60
Study 28283245 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study 25622882 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-alveolar chlorhexidine (CHX) gel
Number of subjects: 100
Study 25622882 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 23250911 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive servo-ventilation (ASV) combined with medications
Number of subjects: 36
Study 23250911 — intervention group
Group type: COMPARATOR
Intervention: Non-ASV treatment (control group)
Number of subjects: 36
Study 21564445 — intervention group
Group type: EXPERIMENTAL
Intervention: Involvement of nurse specialists for 1 year
Number of subjects: 384
Study 21564445 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 384
Study 21564445 — intervention group
Group type: EXPERIMENTAL
Intervention: Involvement of nurse specialists for 1 year (in patients without baseline anxiety/depression)
Number of subjects: 384
Study 18366697 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of Data Monitoring Committees (DMCs) in RCTs
Number of subjects: 79396
Study 18366697 — intervention group
Group type: EXPERIMENTAL
Intervention: Interim analysis without DMC involvement
Number of subjects: 79396
Study 18366697 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendations leading to biased results
Number of subjects: 79396
Study 18366697 — intervention group
Group type: EXPERIMENTAL
Intervention: Sample size re-estimation
Number of subjects: 79396
Study 18366697 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes to trial endpoints
Number of subjects: 79396
Study 15899448 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrophilic acrylic single-piece IOL
Number of subjects: 106
Study 15899448 — intervention group
Group type: COMPARATOR
Intervention: Hydrophobic acrylic single-piece IOL
Number of subjects: 106
Study 12974971 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (HFOV)
Number of subjects: 0
Study 12974971 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 0
Study 10755201 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril (40 mg)
Number of subjects: 187
Study 10755201 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (3 x 50 mg)
Number of subjects: 187
Study 10755201 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study 8689766 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine
Number of subjects: 0
Study 8689766 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxepin
Number of subjects: 0
Study 8689766 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 0
Study 2021872 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate (BDP) for 6 weeks
Number of subjects: 16
Study 2021872 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (Bu) for 6 weeks
Number of subjects: 16
Study 2021872 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific control mentioned)
Number of subjects: 16
Study 6588271 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemofiltration (HF)
Number of subjects: 6
Study 6588271 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD)
Number of subjects: 6
Study 6588271 — intervention group
Group type: COMPARATOR
Intervention: Both HF and HD
Number of subjects: 6
Study 6588271 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma ammonia levels
Number of subjects: 6
Study 31935579 — intervention group
Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 22
Study 31935579 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinidine
Number of subjects: 22
Study 31935579 — intervention group
Group type: COMPARATOR
Intervention: Ranolazine
Number of subjects: 22
Study 31935579 — intervention group
Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 22
Study 31935579 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 31338790 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive intervention (Michael's game) alongside standard treatment for psychosis
Number of subjects: 172
Study 31338790 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment for psychosis
Number of subjects: 172
Study 27607571 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 14671
Study 27607571 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14671
Study 27607571 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin therapy
Number of subjects: 14671
Study 27607571 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 14671
Study 27070732 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe cannabis use (31-240 joints at baseline and 10-196 joints at follow-up)
Number of subjects: 60
Study 27070732 — intervention group
Group type: EXPERIMENTAL
Intervention: High (reducing) cannabis use (31-240 joints at baseline and 0-9 joints at follow-up)
Number of subjects: 60
Study 25134001 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-fructose beverage (1.55 g·min, 2:1 ratio)
Number of subjects: 8
Study 25134001 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-glucose beverage (1.03 g·min)
Number of subjects: 8
Study 25134001 — intervention group
Group type: EXPERIMENTAL
Intervention: High-glucose beverage (1.55 g·min)
Number of subjects: 8
Study 25134001 — intervention group
Group type: COMPARATOR
Intervention: Placebo (artificially sweetened)
Number of subjects: 8
Study 22042731 — intervention group
Group type: EXPERIMENTAL
Intervention: Short waiting period (n=23)
Number of subjects: 60
Study 22042731 — intervention group
Group type: COMPARATOR
Intervention: Long waiting period (n=37)
Number of subjects: 60
Study 19507291 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial fall prevention intervention
Number of subjects: 392
Study 19507291 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 392
Study 17475386 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 68
Study 17475386 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 68
Study 15665657 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy isoflavone supplementation (110 mg/day)
Number of subjects: 19
Study 15665657 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy isoflavone supplementation
Number of subjects: 19
Study 12521500 — intervention group
Group type: EXPERIMENTAL
Intervention: Membrane stripping
Number of subjects: 137
Study 12521500 — intervention group
Group type: COMPARATOR
Intervention: Gentle cervical examination (Control)
Number of subjects: 137
Study 12521500 — intervention group
Group type: COMPARATOR
Intervention: Membrane stripping and Gentle cervical examination (Control)
Number of subjects: 137
Study 10193289 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg
Number of subjects: 120
Study 10193289 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 8 mg
Number of subjects: 120
Study 10193289 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg with Dexamethasone 8 mg
Number of subjects: 120
Study 8594966 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (6 mg/kg body weight)
Number of subjects: 171
Study 8594966 — intervention group
Group type: EXPERIMENTAL
Intervention: Prilocaine (7 mg/kg body weight)
Number of subjects: 171
Study 8594966 — intervention group
Group type: EXPERIMENTAL
Intervention: Ohmeda BIOX 3700e
Number of subjects: 171
Study 8594966 — intervention group
Group type: EXPERIMENTAL
Intervention: Critikon Oxyshuttle
Number of subjects: 171
Study 8594966 — intervention group
Group type: EXPERIMENTAL
Intervention: Nellcor N 180
Number of subjects: 171
Study 2234207 — intervention group
Group type: EXPERIMENTAL
Intervention: Semiannual screening by X-ray and sputum cytology
Number of subjects: 6000
Study 2234207 — intervention group
Group type: COMPARATOR
Intervention: Screening at a 3-year interval
Number of subjects: 6000
Study 702289 — intervention group
Group type: EXPERIMENTAL
Intervention: Suspension A
Number of subjects: 12
Study 702289 — intervention group
Group type: COMPARATOR
Intervention: Suspension B (Control)
Number of subjects: 12
Study 28007717 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of PUFA twice daily
Number of subjects: 561
Study 28007717 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 561
Study 25810469 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based intervention with community health worker (promotora) model and entertainment-education component
Number of subjects: 180
Study 25810469 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based intervention
Number of subjects: 180
Study 24304987 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral approach for bilateral decompression
Number of subjects: 60
Study 24304987 — intervention group
Group type: COMPARATOR
Intervention: Conventional laminectomy
Number of subjects: 60
Study 21509675 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine (100 mg per day) combined with Chinese medicine (CM) treatment for 12 weeks
Number of subjects: 120
Study 21509675 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine (100 mg per day) alone for 12 weeks
Number of subjects: 120
Study 19538406 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural childbirth preparation with psychoprophylactic training (breathing and relaxation techniques)
Number of subjects: 2151
Study 19538406 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal education without psychoprophylactic training
Number of subjects: 2151
Study 19538406 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural childbirth preparation with psychoprophylactic training
Number of subjects: 2151
Study 16780253 — intervention group
Group type: EXPERIMENTAL
Intervention: Static sport
Number of subjects: 110
Study 16780253 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic sport
Number of subjects: 110
Study 16780253 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 110
Study 15302053 — intervention group
Group type: COMPARATOR
Intervention: Normothermic CPB (n=30, temp=35 degrees C)
Number of subjects: 60
Study 15302053 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential temperature management (Cobra cannula)
Number of subjects: 60
Study 15302053 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Normothermic CPB and Differential temperature management)
Number of subjects: 60
Study 11176398 — intervention group
Group type: EXPERIMENTAL
Intervention: Total androgen blockade for 1 month before prostatectomy
Number of subjects: 147
Study 11176398 — intervention group
Group type: COMPARATOR
Intervention: No total androgen blockade
Number of subjects: 147
Study 11176398 — intervention group
Group type: COMPARATOR
Intervention: Total androgen blockade
Number of subjects: 147
Study 9322446 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone (0.25 mg/kg bolus, cumulative dose 0.5 mg/kg)
Number of subjects: 21
Study 9322446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 8227480 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril 1 mg once daily
Number of subjects: 31
Study 8227480 — intervention group
Group type: COMPARATOR
Intervention: Trandolapril 0.5 mg twice daily
Number of subjects: 31
Study 3510525 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem-SR 240 mg/day
Number of subjects: 18
Study 3510525 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem-SR 360 mg/day
Number of subjects: 18
Study 3510525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 29664681 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium/olodaterol with ExT
Number of subjects: 0
Study 29664681 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium/olodaterol without ExT
Number of subjects: 0
Study 29664681 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium/olodaterol with or without ExT
Number of subjects: 0
Study 29664681 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium/olodaterol plus ExT
Number of subjects: 0
Study 29664681 — intervention group
Group type: COMPARATOR
Intervention: SMBM plus placebo
Number of subjects: 0
Study 27344296 — intervention group
Group type: EXPERIMENTAL
Intervention: Radium-223 (50 kBq/kg, intravenous injection) every 4 weeks for six cycles
Number of subjects: 921
Study 27344296 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 921
Study 24009292 — intervention group
Group type: EXPERIMENTAL
Intervention: Divided dosing (BD) prednisolone
Number of subjects: 22
Study 22424346 — intervention group
Group type: EXPERIMENTAL
Intervention: Early operation (≤1 month)
Number of subjects: 36
Study 22424346 — intervention group
Group type: COMPARATOR
Intervention: Late operation (>1 month)
Number of subjects: 36
Study 20211573 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-Tenon's ropivacaine 1% (2.5-3 mL)
Number of subjects: 16
Study 20211573 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (2.5-3 mL) in the control group
Number of subjects: 16
Study 18711765 — intervention group
Group type: COMPARATOR
Intervention: Western medicine therapy (WM)
Number of subjects: 396